Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.
Open Access
- 1 May 1986
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 83 (9) , 2984-2988
- https://doi.org/10.1073/pnas.83.9.2984
Abstract
We have examined the position of the chromosomal breakpoint relative to the human c-myc gene (MYC) and the presence of other structural alterations of the same locus in 19 fresh samples of Burkitt lymphoma (BL) and 13 BL-derived cell lines. This panel includes the two pathogenetic forms of BL: the endemic (African-type) BL (eBL) and sporadic (American-type) BL (sBL). In all cases tested, including fresh samples and cell lines, structural alterations of the 5'' portion of the gene were detected, suggesting that they may be necessary for c-myc activation. However, the site of chromosomal breakpoint and the type of structural alterations differ in eBL and sBL. In 16 of 18 sBL cases, chromosomal translocation truncates the gene within a 5'' region that includes the first intron, the first exon, and 5'' flanking sequences. Conversely, in 14 of 14 eBL samples, the chromosomal breakpoint is located outside the c-myc locus, yet the same 5-sequences are affected by several mutations identifiable by restriction enzyme polymorphisms. Different genetic mechanisms may therefore be involved in chromosomal translocation/c-myc activation, and these differences may be a function of differences in the stage of differentiation of eBL versus sBL.This publication has 25 references indexed in Scilit:
- Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumorsCell, 1985
- A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphomaCell, 1984
- POSSIBLE DUALITY IN BURKITT LYMPHOMA ORIGINThe Lancet, 1984
- Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cellsCell, 1984
- Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locusNature, 1984
- Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factorCell, 1983
- The human c-myc oncogene: Structural consequences of translocation into the igh locus in Burkitt lymphomaCell, 1983
- onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patientNature, 1982
- Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphomaNature, 1982
- Burkitt's LymphomaNew England Journal of Medicine, 1981